Search results
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 7 days agoThe RSV vaccine could be a big moneymaker for Moderna in the future. Moderna stock...Similarly,...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 4 days agoOn Friday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 7 days agoBut Moderna expects the lion's share of its sales to come in the second half of 2024. That lines up...
Moderna Investors Just Got Some Bullish News
Motley Fool via Yahoo Finance· 4 days agoFirst, its RSV vaccine wasn't linked to any cases of Guillain-Barré syndrome in late-stage clinical trials (the Pfizer and GSK...prompt some healthcare...
S2 Episode 6: When RSV Hits Home: Community Care in Rural West Virginia
Medscape· 3 days agoFor more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify,...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 4 days agoLaunching mResvia won't be easy In May 2023, the FDA approved Arexvy, a respiratory syncytial virus...
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post· 23 hours agoKashyap Patel looked forward to his team’s Friday lunches. It was 2021, a year into the coronavirus...
What should you do if you’re still testing positive for COVID-19 after day 10?
The Today Show via AOL· 2 days agoSome of those symptoms — congestion, sore throat, cough, fever — might be easily confused with other...
Why do I keep getting colds every few weeks? 4 reasons why
TODAY via Yahoo News· 2 days agoThat includes COVID-19, but also other illnesses, like the flu and RSV. Test for COVID-19. Even if...
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 1 day agoThe American Society of Clinical Oncology held its annual conference in Chicago this past week,...